GlassScriptPhysician profile
Melanie Anon
NPI 1427743657
$1,251.39
in general payments reported to CMS, 2019-2025
16 companies · $475 in 2025
The $475 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $34.56 · 2024: $742 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,251.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $203.45 | 2024-2025 | Aristada, Lybalvi |
| E.R. Squibb & Sons, L.L.C. | $130.88 | 2024-2025 | Cobenfy |
| Takeda Pharmaceuticals U.S.A., INC. | $130.77 | 2024 | Trintellix |
| Janssen Pharmaceuticals, INC | $119.67 | 2024-2025 | Spravato |
| Otsuka America Pharmaceutical, INC. | $109.93 | 2024-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $108.02 | 2024-2025 | Caplyta |
| Lundbeck LLC | $95.48 | 2024-2025 | Rexulti |
| Axsome Therapeutics, INC. | $83.94 | 2024-2025 | Auvelity |
| Revance Therapeutics, INC. | $70.08 | 2025 | Daxxify |
| Abbvie INC. | $68.13 | 2024-2025 | |
| Supernus Pharmaceuticals, INC. | $55.10 | 2023-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $20.61 | 2024 | |
| Acadia Pharmaceuticals INC | $19.58 | 2025 | Nuplazid |
| Tris Pharma INC | $14.57 | 2025 | Dyanavel Xr |
| Neurocrine Biosciences, INC. | $13.99 | 2024 | Ingrezza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $7.19 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Anon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.